Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| RSGPB-07-285-01-CPPB | Other Identifier | American Cancer Society |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Cancer Society, Inc. | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Writing Type 1 | Experimental |
| |
| Experimental Writing type 2 | Experimental |
| |
| Control writing type 1 | Active Comparator |
| |
| Control writing type 2 | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Writing A (Experimental informative writing) | Behavioral | Experimental informative writing |
|
| Measure | Description | Time Frame |
|---|---|---|
| Psychological Adjustment | At screening, baseline and 3 months following intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life | At screening, baseline and 3 months following intervention |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christine Rini, Ph.D. | Icahn School of Medicine at Mount Sinai | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hackensack University Medical Center | Hackensack | New Jersey | 07601-1991 | United States | ||
| Mount Sinai School of Medicine |
Not provided
Not provided
Not provided
Not provided
Not provided
| Writing B (Experimental noninformative writing) | Behavioral | Experimental noninformative writing |
|
| Writing C (Control informative writing) | Behavioral | Control informative writing |
|
| Writing D (Control noninformative writing) | Behavioral | Control noninformative writing |
|
| New York |
| New York |
| 10029 |
| United States |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599-6011 | United States |
| ID | Term |
|---|---|
| D007938 | Leukemia |
| D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| D009101 | Multiple Myeloma |
| D000741 | Anemia, Aplastic |
| D008206 | Lymphatic Diseases |
| D007945 | Leukemia, Lymphoid |
| D007160 | Immunoproliferative Disorders |
| D000740 | Anemia |
| D008232 | Lymphoproliferative Disorders |
| D008223 | Lymphoma |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007154 | Immune System Diseases |
| D054219 | Neoplasms, Plasma Cell |
| D020141 | Hemostatic Disorders |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010265 | Paraproteinemias |
| D001796 | Blood Protein Disorders |
| D006474 | Hemorrhagic Disorders |
| D000080983 | Bone Marrow Failure Disorders |
| D001855 | Bone Marrow Diseases |
Not provided
Not provided